Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cohen & Steers (CNS) Shares Outstanding (Weighted Average) (2016 - 2026)

Cohen & Steers' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $51.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 0.75% to $51.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.4 million, a 0.75% increase, with the full-year FY2025 number at $51.2 million, up 1.51% from a year prior.
  • Shares Outstanding (Weighted Average) hit $51.4 million in Q1 2026 for Cohen & Steers, up from $51.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CNS hit a ceiling of $51.4 million in Q1 2026 and a floor of $48.7 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $49.9 million across 5 years, with a median of $49.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 3.0% in 2025 and later grew 0.75% in 2026.
  • Tracing CNS's Shares Outstanding (Weighted Average) over 5 years: stood at $48.8 million in 2022, then increased by 1.08% to $49.3 million in 2023, then increased by 2.23% to $50.4 million in 2024, then grew by 1.51% to $51.2 million in 2025, then rose by 0.53% to $51.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CNS at $51.4 million in Q1 2026, $51.2 million in Q4 2025, and $51.1 million in Q3 2025.